Spiroindolines Identify the Vesicular Acetylcholine Transporter as a Novel Target for Insecticide Action by Sluder, Ann et al.
Spiroindolines Identify the Vesicular Acetylcholine
Transporter as a Novel Target for Insecticide Action
Ann Sluder
1¤a, Sheetal Shah
2¤b,   Je ´ ro ˆ me Cassayre , Ralph Clover , Peter Maienfisch , Louis-
3 1 3
Pierre Molleyres
3, Elizabeth A. Hirst
2, Anthony J. Flemming
2, Min Shi
2, Penny Cutler
2, Carole Stanger
2,
Richard S. Roberts
2¤c, David J. Hughes
2, Thomas Flury
3, Michael P. Robinson
2, Elke Hillesheim
3,
Thomas Pitterna
3, Fredrik Cederbaum
3, Paul A. Worthington
2, Andrew J. Crossthwaite
2,
John D. Windass
2, Richard A. Currie
2, Fergus G. P. Earley
2*
1Cambria Biosciences, Woburn, Massachusetts, United States of America, 2Syngenta Crop Protection Research, Bracknell, Berkshire, United Kingdom, 3Syngenta Crop
Protection AG, Stein, Switzerland
Abstract
The efficacy of all major insecticide classes continues to be eroded by the development of resistance mediated, in part, by
selection of alleles encoding insecticide insensitive target proteins. The discovery of new insecticide classes acting at novel
protein binding sites is therefore important for the continued protection of the food supply from insect predators, and of
human and animal health from insect borne disease. Here we describe a novel class of insecticides (Spiroindolines)
encompassing molecules that combine excellent activity against major agricultural pest species with low mammalian
toxicity. We confidently assign the vesicular acetylcholine transporter as the molecular target of Spiroindolines through the
combination of molecular genetics in model organisms with a pharmacological approach in insect tissues. The vesicular
acetylcholine transporter can now be added to the list of validated insecticide targets in the acetylcholine signalling
pathway and we anticipate that this will lead to the discovery of novel molecules useful in sustaining agriculture. In addition
to their potential as insecticides and nematocides, Spiroindolines represent the only other class of chemical ligands for the
vesicular acetylcholine transporter since those based on the discovery of vesamicol over 40 years ago, and as such, have
potential to provide more selective tools for PET imaging in the diagnosis of neurodegenerative disease. They also provide
novel biochemical tools for studies of the function of this protein family.
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Introduction
Increasing demand for food, fuel and fibre crops from limited
agricultural land area will drive more intensive agricultural
practices that are more vulnerable to losses from pests and
disease. The need for effective control of insect pests in agriculture
is therefore becoming more important [1,2,3]. Reliable insect
control requires the development of novel insecticides that
overcome resistance against existing classes in pest populations,
and this is not only an issue for all major agrochemical classes, but
also has become a critical issue for human and animal health
[4,5,6]. One form of resistance is a consequence of selection for
less sensitive forms of the insecticide target protein, and so
insecticides that target novel proteins are valuable developments.
Here we report the discovery of an insecticide class that acts at the
vesicular acetylcholine transporter, a novel target for insect
control. Identification of this protein as the target delivering the
insecticidal effect was driven by a forward genetics approach in
model organisms and harnessed the gene function knowledge base
in the free living nematode Caenorhabditis elegans.
In nematodes and vertebrates, acetylcholine acts as a fast
excitatory neurotransmitter at neuronal synapses and at the
neuromuscular junction, whereas in insects its role in this respect is
restricted to the central nervous system [7]. Preceding its release
into the synapse, acetylcholine is synthesized in the presynaptic
terminal and loaded into specialized storage and release vesicles
through the action of the vesicular acetylcholine transporter
(VAChT), a member of the major facilitator superfamily closely
related to the monoamine neurotransmitter transporters and
believed to be structurally related to bacterial transporters [8]. In
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e34712Figure 1. From hit to lead: selected structures of Spiroindolines. a) 1: insecticidal hit identified through high-throughput screening; b)
SYN351: lead compound used in studies of resistance in C.elegans and D.melanogaster (prepared according to path b in Figure 2); c) SYN876: lead
compound tested in the field for insecticidal activity (prepared according to path a in Figure 2) and used as radioligand ([
3H]- SYN876 prepared
according to path d in Figure 2).
doi:10.1371/journal.pone.0034712.g001
Figure 2. General structure of Spiroindolines and major synthetic routes: a) Fischer Indole synthesis with flexible variation of R1;
b) alternative Fischer Indole synthesis allowing convergent variation at R3; c) alternative, novel synthetic pathway through intramolecular Heck
reaction allowing broad variation at R2; and d) functionalisation of piperidine ring (X1,X 2=H,
3H, F). Detailed methods are provided in on-line
materials.
doi:10.1371/journal.pone.0034712.g002
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VAChT is encoded by a single gene at a complex locus that also
contains the coding sequence for the biosynthetic enzyme
cholineacetyltransferase [9].
The acetylcholine signalling pathway has already been success-
fully exploited by several insecticide classes of major commercial
importance acting either as acetylcholinesterase inhibitors (organ-
ophosphates and carbamates), which are now in declining use
because of resistance and safety issues; or as nicotinic acetylcholine
receptor activators (neonicotinoids and spinosyns), for which
resistance is an emerging problem for both agriculture and animal
health [10,11].
Results
The Discovery of Insecticidal Spiroindolines and
Optimization of their Biological Activity
Organic compounds incorporating the spiro[indoline-3,4’-
piperidine] scaffold have been reported to induce several
pharmaceutical effects and the scaffold is considered as a
‘‘privileged component’’ of G-protein coupled receptor ligands
[12,13]. High throughput screening of a spiroindoline chemical
library for insecticidal activity led to the identification of several
insecticidal spiro[indoline-3,4’-piperidine] compounds, including
compound 1 (Figure 1), which displayed significant activity against
the insect species D. melanogaster, Plutella xylostella (diamond-
back moth) and Heliothis virescens (tobacco budworm) at
1000 mg.ml
21 (see online Methods and Validation). Intrigued by
a possible extension of the privileged nature of this structural
scaffold to crop protection research, we embarked on an
optimization program around this initial lead which resulted in
the identification of highly potent and selective insecticides such as
SYN351 and SYN876 [14]. The Fischer-Indole reaction was
found to be a reliable route for the synthesis of spiro[indoline-3,4’-
piperidine] compounds as previously described [15,16], and this
methodology was improved and applied to the convergent
functionalization of the indoline (Figure 2, path a) or the
piperidine nitrogen (path b). We also devised a novel route based
on an intramolecular Heck reaction for the synthesis of
spiroindolines with electron-poor aromatic rings as well as
the further functionalization of the piperidine ring (path c) [17].
The latter route was used for the synthesis of the radioligand [3H]-
SYN876 after tritiation of the piperidine double bond (path d).
The biological activity of a selected set of compounds against
Spodoptera littoralis (cotton leafworm), H. virescens and P. xylos-
tella is shown in Table S1. The 4-nitrobenzoyl indoline substituent
in compound 1 was replaced by an isonicotinoyl group, giving
increased potency and photo stability (Table S1, entry 1).
Introduction of a halogen atom on the aromatic ring of the
indoline (entry 2) or the cinnamyl cap (entry 3) had a positive and
cumulative effect (entry 4) on insecticidal activity that could not be
accounted for by changes in activity at the target protein (entries
24 and 26, tables S2 and S3), and so is a probable result of
increased metabolic stability [18]. Structure-activity relationships
revealed in particular the importance of the cinnamyl substituent
at the piperidine nitrogen (Table S1 entries 4, 6 and 7) as well its
(E)-double bond geometry (entry 5). With SYN351 and SYN876
(entries 4 and 8), an optimal substitution pattern was found and
Figure 3. Field efficacy of SYN876 at different application rates, expressed as percent insect control compared with untreated
plots. Pest and application rates are given on the x axis. Each point represents data from an independent trial and is an average of multiple
assessments. Full details are given in online methods.
doi:10.1371/journal.pone.0034712.g003
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evaluation and mode of action studies.
As a representative member of the family, the lead Spiroindo-
line SYN876 is slightly basic (pKa 7.88), displays high lipophilicity
(logP 5.94), low water solubility (H2O sol. 5 mg.ml
21 at pH 6.15),
and exhibits moderate photostability (T50 114 mins). Its efficacy in
the field against representative lepidopteran pests is shown in
Figure 3, and was found to approach or exceed that of commercial
standards such as Spinosad [19]. Moreover, besides its high level
Figure 4. Spiroindolines induce coiling (A) and inhibit pharyngeal pumping (B) in C. elegans. Wild-type (N2) animals treated with SYN351
(shown) or SYN876 grow slowly and display a coiling, ‘‘loopy’’ posture during locomotion (right panel) compared to controls (left panel). Pharyngeal
pumping rate was determined for four wild-type (N2) animals at each concentration of SYN876, by manually counting the contractions of the
posterior bulb of the pharynx over one minute.
doi:10.1371/journal.pone.0034712.g004
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e34712Figure 5. cha-1(p1152) is hypersensitive to SYN876. Staged L1 hermaphrodite larvae were plated onto agar culture medium (,50 animals/well
of a 24 well microplate) containing SYN876 added as a concentrated solution in dimethylsulphoxide (DMSO) to give the indicated final
concentrations. The final concentration of DMSO in all assays was 1%. Micrographs show growth after 3 days.
doi:10.1371/journal.pone.0034712.g005
Figure 6. Sublethal doses of SYN876 suppress aldicarb effects. Wild-type C. elegans was exposed to the indicated compound concentrations.
Worms exposed to 1 mM aldicarb are hypercontracted and exhibit little movement (lower left panel). In the presence of both 1 mM aldicarb and
1 mg.ml
-1 SYN876 the worms are much less hypercontracted and exhibit fairly normal sinusoidal locomotion (arrow, lower right panel). Worms
exposed to 1 mM aldicarb and .2.5 mg/ml SYN876 exhibit movement and growth defects similar to those induced by SYN876 alone (uncoordinated
movement and coiling without hypercontraction; not shown).
doi:10.1371/journal.pone.0034712.g006
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toxicity in rats (MLD50 .200 mg.kg
21).
The Effects of Insecticidal Spiroindolines on
Caenorhabditis Elegans and Characterization of Resistant
Mutants
Spiroindolines are toxic to C. elegans, in which they induce an
uncoordinated ‘‘loopy’’, coiling locomotion and reduced frequency
of pharyngeal pumping (Figure 4), symptoms that are similar to
the phenotypes of mutants in which neuromuscular cholinergic
signalling is reduced [20]. Animals bearing a partial loss of
function mutation in choline acetyltransferase (ChAT), which
produce reduced levels of acetylcholine, are hypersensitive to
Spiroindolines (Figure 5). One simple explanation for these
observations is that the Spiroindolines somehow act to reduce
the availability of acetylcholine at the synapse.
To test this hypothesis more directly, we examined the
interaction of SYN876 with the cholinesterase inhibitor aldicarb.
Exposure to aldicarb leads to muscle hypercontraction and
eventual nematode death, and mutants such as cha-1 that produce
reduced levels of acetylcholine are resistant to aldicarb since they
are more able to tolerate some increase in synaptic acetylcholine
levels than wild-type nematodes. Furthermore, low levels of
aldicarb suppress the movement and growth defects of these
mutants [21]. We therefore reasoned that if the Spiroindolines act
to reduce synaptic acetylcholine levels, they would be able to
suppress the effects of aldicarb. Consistent with this hypothesis,
sub-lethal doses of SYN876 ameliorated the effects of aldicarb
exposure (Figure 6).
Chemical mutagenesis generated C. elegans mutants resistant to
Spiroindolines (Figure 7). The low frequency of recovery and
genetic dominance of the mutations indicated that resistance was
due to gain of function. Mutations conferring resistance mapped to
a 5 map unit interval on Chromosome IV that contains the genes
for VAChT (unc-17) and ChAT (cha-1) (see Text S1). The
apparent requirement for a gain-of-function mutation to confer
resistance further suggested that the mutations affected an essential
gene (or genes), and it is known that both unc-17 and cha-1
function are required for nematode viability [22,23]. All mutants
characterized had sequence changes in the coding region of unc-
17 that resulted in amino acid substitutions (Figure 8), providing
compelling evidence that unc-17 is the locus encoding resistance.
The C203Y and Y411N mutations were each recovered in two
independent lines, suggesting that very few changes allow for both
Spiroindoline resistance and nematode viability.
Generation of Resistance to Spiroindolines in Drosophila
Melanogaster
To confirm that the results from nematodes were applicable to
insects, we tested whether the same amino acid substitutions could
also generate resistance in D. melanogaster. Wild-type, and
variant forms of D. melanogaster VAChT (Y49N and E341K in
the Drosophila protein corresponding to strong and weak
C. elegans resistance alleles cb34 and cb28 respectively) were
ectopically expressed using the Gal4-UAS modular misexpression
system [24]. Expression of the variants was driven by the cha
promoter, thus mimicking the endogenous expression pattern of
vacht. Multiple independent lines were tested for each variant and
viable insects with no remarkable phenotypes were recovered
for all.
Flies over-expressing the wild-type form of the vacht gene,
cha.vacht+, were at least 3-fold less susceptible than control
genotypes to SYN351-mediated mortality, demonstrating that
Figure 7. The effect of two Spiroindolines and vesamicol on the
survival of parental and mutant C. elegans larvae to adulthood.
Black lines represent sensitivity of the wild-type strain N2. Coloured
lines represent sensitivity of the mutant alleles selected for resistance to
SYN351; cb28 (magenta), cb29 (red), cb30 (green), cb34 (cyan). Solid
symbols represent the means, and bars represent the maximum and
minimum values for three replicate experiments. The amino acid
change for each mutant allele is indicated in Figure 8.
doi:10.1371/journal.pone.0034712.g007
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SYN351. Flies over-expressing one mutant form of the vacht gene,
cha.vacht
Y49N, were completely insensitive to all doses of
SYN351 tested over an extended period of time (Table 1). These
results indicated that a single amino acid change in the VAChT
protein is capable of generating very high levels of resistance, and
that the expression of VAChT[Y49N] in a wild type background is
sufficient to overcome the toxic effect of this compound in
Drosophila. Thus the mechanism of resistance to SYN351
translates from worms to flies and relates to the function of
VAChT.
None of the flies engineered to over-express the E341K mutant
form of the vacht gene, cha.vacht
E341K, were resistant to
SYN351-mediated mortality. These flies did not even exhibit the
same level of resistance as Cha.vacht+ flies. One explanation for
this observation is that the VAChT E341K variant protein is
either not expressed or is unstable relative to the ectopic expression
of VAChT+, and this inference was supported by the failure to
detect elevated levels of the protein by western blotting [data not
shown].
A High Affinity Binding Site for Spiroindolines in Insect
Tissues and its Relationship to the Vesicular
Acetylcholine Transporter
It remained a possibility that Spiroindolines did not act directly
at VAChT, either because mutations in VAChT are able to
compensate for other effects, or because changes to the transport
activity of VAChT were able to reduce exposure (VAChT has a
broad substrate specificity [25]). A complementary approach to
the characterization of the target protein allowed us to address this
possibility.
Figure 8. VAChT Protein sequence alignments for transmembrane domains in which amino acid changes gave rise to resistance to
SYN351. The C. elegans sequence is aligned with those from four insect species; D. melanogaster (dromel), Manduca sexta (mansex), Tribolium
castanaeum (tricas) and, Acyrthosiphon pisum (acypis); the human (homosap) and rat sequence (VACHT_RAT), and corresponding sequences of the rat
monoamine transporters. Predicted transmembrane helices (TM) are marked by grey bars. The sequence changes in C. elegans unc-17 mutants
resistant to Spiroindolines are indicated by the arrows.
doi:10.1371/journal.pone.0034712.g008
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binding of [3H]-SYN876 to tissue homogenates from different
insect species were established, revealing a very high affinity
binding site at a concentration similar to that seen for the vesicular
monoamine transporter in brain regions rich in dopaminergic
neurons [26] (Figure 9a). Displacement assays demonstrated that
the pharmacology of this binding site with respect to a variety of
spiroindoline analogues was well conserved across insect orders
(Figure 9b). Insecticidal spiroindolines generally had IC50’s in the
low nM range in this assay, whereas a broad range of insecticides
and drugs, diverse in terms of their chemical structure and known
biochemical targets, were inactive at concentrations in the 1–
10 mM range (table S4). These studies demonstrated the novelty
and specificity of the binding site in the context of insecticide
action. Correlation of the potency of spiroindoline analogues in
the displacement assay with biological activity against lepidopteran
larvae (Figure 10) indicated the relevance of this binding
interaction to the insecticidal effect.
A binding site with very similar properties was produced in
PC12 cells when transformed to express the D. melanogaster gene
for VAChT (Figure 11), and it was shown that binding to this site
and to the site in insect tissues was displaced by the known
VAChT inhibitors vesamicol and aminobenzovesamicol (table S3).
Thus it is clear that the Spiroindoline binding site in insect tissues
corresponds to VAChT. Expression of D. melanogaster VAChT
in PC12 cells allowed us to demonstrate that insecticidal
spiroindolines are potent inhibitors of VAChT mediated transport
of acetylcholine (Figure 11 and table S3).
Discussion
As information is gathered on the activity of chemical libraries
against a large number of drug targets, it becomes increasingly
apparent that biologically active organic chemicals are rarely
specific in their actions [27,28]. Indeed, the ability of certain
structural templates to interact with multiple receptors has been
recognized since the 1980’s and led to the concept of privileged
chemical structures [29]. For this reason it is not advisable to reach
conclusions about the mechanism of a particular biological effect
based solely on structural features of the ligand or its activity
against isolated targets. In our own studies on isolated systems,
early insecticidal spiroindolines showed activity against both the
nicotinic acetylcholine receptor and voltage gated sodium channel
at mM concentration (data not shown), targets that are unrelated to
each other and to G-protein coupled receptors for which the
spiroindoline scaffold is considered a privileged structure.
Pharmacological specificity is inversely related to dose, and so
for very potent insecticides it is expected that the number of
potential molecular interactions that could account for the
biological effect will be small. However, the relationship between
applied dose and concentration at the molecular target can often
be confounded by clearance mechanisms, transport barriers,
bioaccumulation, or a requirement for metabolic activation. So, to
confidently assign any observed molecular interaction of a drug or
agrochemical to its biological effect it is necessary to relate one to
the other through experimental manipulation and correlation.
The generation of resistance through mutagenesis is a powerful
tool in this respect because it can quickly identify molecular
Table 1. Resistance to SYN351 generated by ectopic expression of VAChT in D. melanogaster.
Comparisons between test and parental genotypes Resistance factors (95% confidence limits)
(i) Cha.vacht
+(1-3): Cha 3.54 (2.03 – 6.52)
Cha.vacht
+(1-3): vacht
+(1-3) 3.57 (2.03 – 6.53)
Cha.vacht
+(1-7): Cha 3.07 (1.75 – 5.68)
Cha.vacht
+(1-7): vacht
+(1-7) 4.03 (2.28 – 7.44)
(ii) Cha.vacht
Y49N(18): Cha .74.4
Cha.vacht
Y49N(18): vacht
Y49N(18) .180.2
Cha.vacht
Y49N(19): Cha .74.4
Cha.vacht
Y49N(19): vacht
Y49N(19) .252.9
Cha.vacht
Y49N(24): Cha .723
Cha.vacht
Y49N(24): vacht
Y49N(24) .2607
(iii) Cha.vacht
E341K(5): Cha 0.83 (0.55 – 1.26)
Cha.vacht
E341K(5): vacht
E341K(5) 2.8 (1.8 – 4.2)
Cha.vacht
E341K(7): Cha 0.47 (0.31 – 0.71)
Cha.vacht
E341K(7): vacht
E341K(7) 1.3 (0.8 – 1.9)
Cha.vacht
E341K(9): Cha 1.63 (0.97 – 2.74)
Cha.vacht
E341K(9): vacht
E341K(9) 5.29 (3.09 – 9.29)
Resistance factors are ratios of LD50 values obtained by fitting a regression analysis to the relationship between % mortality and log (dose); parallel regression was
accepted as the model for all the data. All genotypes are described in the online methods.
Resistance factors for ectopic expression of the wild-type vacht transgene in two independent lines, as compared to the parental genotypes (Cha and vacht
+(12n)).
Resistance factors for ectopic expression of the vacht
Y49N transgene in three independent lines, as compared to the parental genotypes. Since no mortality was
observed at the highest dose tested (1 mg.ml
21), resistance factors are the minimum expected based on estimates of LD50 that assume parallel dose response curves
to those observed in (i).
(i) Resistance factors for ectopic expression of the vacht
E341K transgene in three independent lines, as compared to the parental genotypes. No significant resistance was
detected in the test genotypes compared to both of the parental controls.
doi:10.1371/journal.pone.0034712.t001
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e34712Figure 9. Binding of Spiroindolines in insect tissues. A - Saturation isotherm for the binding of [
3H]-SYN876 in the blowfly L. sericata. Data from
two independent experiments is combined and analyzed by fitting to a single site binding model (y=Bmax * x/(Kd+x)). The line represents the
theoretical curve for the indicated values of Kd and Bmax. B - Two way correlation plots comparing the pharmacology of [
3H]-SYN876 displacement
between insect orders. S. littoralis,(Lepidoptera); L. Sericata, (Diptera); and Locusta migratoria, (Orthoptera). Data for the 24 analogues used is given in
table S3.
doi:10.1371/journal.pone.0034712.g009
Spiroindoline Insecticides Act by Inhibiting VAChT
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e34712changes that give rise to insensitivity at the whole organism level,
sometimes indicating the identity or function of the target protein.
All of the mutations recovered and characterized in this study
resulted in amino acid substitutions in conserved trans-membrane
domains of the transporter (Figure 8). Apart from resistance to
spiroindolines and, in one case, hypersensitivity to vesamicol, the
mutants we recovered had no obvious phenotype as homozygotes.
The genetic dominance of the mutations suggests that they directly
impact the binding interaction with Spiroindolines, however, the
distribution of the variant amino acids in a predicted protein
structure (based on known structures of related bacterial proteins)
does not allow all to form part of the same binding site [8]. Other
available information on the function of amino acids at or close to
the sites we identified indicates that many non-conservative
substitutions result in impaired function, although none of the
changes generated by site directed mutagenesis of the rat gene
[30,31,32], or recovered in phenotypic screens of C. elegans [22,33]
are the same as reported here, so it is not possible to draw
conclusions about the mechanism of resistance without further
study.
Another approach to the identification of the relevant target
protein is through the characterization of the highest affinity
interactions of the ligand in tissues from the target organism. The
very high affinity binding interaction of Spiroindolines in insect
tissues is here linked to VAChT through its known pharmacology
(sensitivity to vesamicol) and through the dependence of binding
on the expression of VAChT in PC12 cells. It is linked to
biological activity by correlation for a large number of Spiroindo-
line analogues. It seems that very potent inhibition of VAChT is a
requirement for lethality, as is almost complete loss of function in
genetic studies [22]. Although the mechanism of resistance has yet
to be confirmed, it is clear from the studies presented here that
Spiroindolines exert their most potent biological effects in insects
and nematodes through inhibition of the transport activity of
VAChT.
Insecticidal spiroindolines are structurally distinct from vesami-
col and its analogues and so represent a novel class of ligand that
should complement vesamicol in studies of the structure and
function of VAChT [34]. Although vesamicol analogues compete
with Spiroindolines for binding, the hypersensitivity of some
Spiroindoline resistant C. elegans mutants to vesamicol (Figure 7)
indicates a different mode of interaction with the protein.
Vesamicol is highly toxic to mammals [40], but is not insecticidal
and to some degree this may be a consequence of selectivity at the
protein level. Vesamicol binds with low nM affinity in vertebrate
tissues [34], but binding could not be detected in insect tissues
(data not shown), presumably because the affinity is too low, as
indicated by the high IC50 for spiroindoline displacement (Table
S4). The spiroindoline SYN876 has favourable acute oral toxicity
in the rat, but is a potent insecticide. Studies of its interaction with
VAChT from vertebrate species will be required to understand to
what degree differential toxicity can be attributed to differences in
binding, and such studies cold also inform strategies to design
selectivity between target and non-target species.
Apart from their utility as insecticides and nematocides,
Spiroindolines may also provide an alternative to vesamicol
analogues for the development of reagents to image cholinergic
neurons in the human brain by positron emission tomography,
potentially useful in the diagnosis and study of a number of
neurodegenerative and psychiatric conditions. Currently available
reagents based on the structure of vesamicol have a number of
limitations for this purpose [35].
Materials and Methods
Materials
Synthetic and analytical methods for Spiroindolines are
described online, as are the sources of other chemicals, reagents
and biological materials.
Preparation and Assay of Fractions from Insect Tissues
and PC12 Cells
Methods for membrane preparation and assays for radioligand
binding and vesicular acetylcholine uptake were adapted from
those previously described for insects [36] and PC12 cells [37].
PC12 cells expressing the D. melanogaster vacht gene were generated
using the Invitrogen
TM GatewayH cloning technology. The
D. melanogaster gene was cloned by high fidelity PCR from a
cDNA library prepared from adult flies.
Production of Spiroindoline Resistant Strains of C. elegans
and D. melanogaster
Resistant C. elegans mutants were selected by exposure to
SYN351 (5 mg.ml
21) from the F2 generation following EMS
mutagenesis using standard methods [38]. Details of mapping are
given in the online methods section. Variant unc-17 sequences
were obtained by PCR cloning from mixed stage C. elegans cultures
(ENA accession numbers: FR852384 (cb28), FR852389 (cb29),
FR852385 (cb30), FR852386 (cb31), FR852387 (cb32) and
FR852388, (cb34)).
D. melanogaster was transformed to over express wild type and
variant vacht using the GAL4-mediated binary expression system
[24] as modified by Griswold et al [39]. The transgenic lines were
crossed to the cha-GAL4 and the elav-GAL4 driver lines to give
tissue specific transgene expression. Genotypes are fully described
in the online methods section.
Bioassays
Insects and nematodes were exposed to test chemicals both
through the diet and by contact. Chemicals were introduced in a
solvent that was also present in the controls and that alone had no
effect on survival. Effects were assessed after 3–6 days of exposure
Figure 10. The relationship between insecticidal activity
against lepidopteran larvae and potency in displacing [3H]-
SYN876 from head membranes of L. sericata. The number of
compounds in each category of biological activity is shown above the
column. Structures of the analogues used and data for the correlation
are given in tables S2 and S3. The category of biological activity was
determined by the lowest EC80 against any of the species tested.
doi:10.1371/journal.pone.0034712.g010
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e34712Figure 11. Binding properties and acetylcholine transport inhibition of SYN876 in PC12 cells expressing D. melanogaster VAChT. A –
Binding of [
3H]-SYN876 to membranes from PC12 cells. Red squares indicate average binding from cells transformed to express D. melanogaster
VAChT, the line represents the theoretical curve for Kd=0.04 nM and Bmax=1.56 pmol.mg
21; blue circles indicate average binding from the same
parent cell line transformed with the control vector; bars indicate maximum and minimum values (n=4 below 0.05 nM [
3H]-SYN876, 2 for data
above). B - Inhibition of the acetylcholine transport activity of PNS from the cells transformed to express D. melanogaster VAChT. Colours indicate
data from six independent experiments.
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PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e34712by manual observation and used to generate dose response curves
from which measures of potency were derived. Acute toxicity in
the rat was assessed 7 days after a single oral dose.
Methods are described in detail in Text S1.
Supporting Information
Text S1 Supplementary methods and validation. This
document contains detailed descriptions of the methods used and
additional results supporting experimental interpretation in the
main text.
(DOC)
Table S1 Insecticidal activity of a selected set of
spiroindoline compounds against lepidopteran larvae.
Activity is given as the concentration giving 80% mortality (EC80
(mg.ml
-1)).Use of , and # indicate that the operator judges the
true EC80 to be well below and a little below, respectively, the
given concentration but above the next lowest concentration
tested.
(DOC)
Table S2 Structures and biological activities of spir-
oindoline analogues. Activity is given as the concentration
giving 80% mortality (EC80 (mg.ml
-1)).Use of , and # indicate
that the operator judges the true EC80 to be well below and a little
below, respectively, the given concentration but above the next
lowest concentration tested.
(DOC)
Table S3 Potency of spiroindoline analogues for dis-
placement of Spiroindoline binding and inhibition of
vesicular acetylcholine uptake. Columns headed with the
insect species names show data for displacement of [
3H]-SYN876
binding. Acetylcholine uptake was measured using a fraction
isolated from PC12 cells expressing Drosophila VAChT. Dis-
placement and inhibition assays are described in the Text S1.
Missing values were not determined. Some values are ranges or
approximations (,) based on a limited number of concentrations
tested; others were determined by curve fitting as described in
Text S1. Compound numbers refer to the structures in Table S2.
(DOC)
Table S4 Pharmacological selectivity of the Spiroindo-
line binding site in L. Sericata. Compounds were assayed for
[3H]-SYN876 displacement as described in Text S1. Compounds
were scored as inactive if they gave less that 20% displacement at
the highest test concentration (nominally 10 mM).
(DOC)
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